Antimicrobial activity of MHC class I-restricted CD8+T cells in human tuberculosis

被引:135
作者
Cho, S
Mehra, V
Thoma-Uszynski, S
Stenger, S
Serbina, N
Mazzaccaro, RJ
Flynn, JL
Barnes, PF
Southwood, S
Celis, E
Bloom, BR
Modlin, RL [1 ]
Sette, A
机构
[1] Univ Calif Los Angeles, Sch Med, Div Dermatol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Sch Med, Dept Microbiol & Immunol, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, Sch Med, Inst Mol Biol, Los Angeles, CA 90095 USA
[4] Harvard Univ, Sch Publ Hlth, Off Dean, Boston, MA 02115 USA
[5] Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA
[6] Univ Texas Hlth Ctr, Ctr Pulm & Infect Dis Control, Tyler, TX 75708 USA
[7] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
[8] Epimmune Inc, San Diego, CA 92121 USA
关键词
D O I
10.1073/pnas.210391497
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Studies of mouse models of tuberculosis (TB) infection have indicated a central role for MHC class I-restricted CD8+ T cells in protective immunity. To define antigens and epitopes of Mycobacterium tuberculosis (MTB) proteins that are presented by infected cells to CD8+ T cells, we screened 40 MTB proteins for HLA class I A*0201-binding motifs, Peptides that bound with high affinity to purified HLA molecules were subsequently analyzed for recognition by CD8+ cytotoxic T lymphocytes, We identified three epitopes recognized by CD8+ T cells from patients recovering from TB infection. Those three epitopes were derived from three different antigens: thymidylate synthase (ThyA(30-38)). RNA polymerase beta -subunit (RpoB(127-135)), and a putative phosphate transport system permease protein A-1 (PstA1(75-83)) In addition, CD8+ T cell lines specific for three peptides (ThyA(30-38). PstA1(75-83), and 85B(15-23)) were generated from peripheral blood mononuclear cells of normal HLA-A*0201 donors. These CD8+ T cell lines specifically recognized MTB-infected macrophages, as demonstrated by production of IFN-gamma and lysis of the infected target cells. Finally, CD8+ cytbtdxic:T lymphocytes reduced the viability of the intracellular MTB, providing evidence that CD8+ T cell recognition of MHC class I-restricted epitopes of these MTB antigens can contribute to effective immunity against the pathogen.
引用
收藏
页码:12210 / 12215
页数:6
相关论文
共 34 条
[1]   Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis [J].
Behar, SM ;
Dascher, CC ;
Grusby, MJ ;
Wang, CR ;
Brenner, MB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (12) :1973-1980
[2]   Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis [J].
Bertoni, R ;
Sidney, J ;
Fowler, P ;
Chesnut, RW ;
Chisari, FV ;
Sette, A .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (03) :503-513
[3]   The death and resurrection of tuberculosis [J].
Bloom, BR ;
McKinney, JD .
NATURE MEDICINE, 1999, 5 (08) :872-874
[4]   TUBERCULOSIS - COMMENTARY ON A REEMERGENT KILLER [J].
BLOOM, BR ;
MURRAY, CJL .
SCIENCE, 1992, 257 (5073) :1055-1064
[5]   Identification of a second Mycobacterium tuberculosis gene cluster encoding proteins of an ABC phosphate transporter [J].
Braibant, M ;
Lefevre, P ;
deWit, L ;
Ooms, J ;
Peirs, P ;
Huygen, K ;
Wattiez, R ;
Content, J .
FEBS LETTERS, 1996, 394 (02) :206-212
[6]   THE RELATION BETWEEN MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) RESTRICTION AND THE CAPACITY OF IA TO BIND IMMUNOGENIC PEPTIDES [J].
BUUS, S ;
SETTE, A ;
COLON, SM ;
MILES, C ;
GREY, HM .
SCIENCE, 1987, 235 (4794) :1353-1358
[7]  
Canaday DH, 1999, J IMMUNOL, V162, P372
[8]   KILLING OF VIRULENT MYCOBACTERIUM-TUBERCULOSIS BY REACTIVE NITROGEN INTERMEDIATES PRODUCED BY ACTIVATED MURINE MACROPHAGES [J].
CHAN, J ;
XING, Y ;
MAGLIOZZO, RS ;
BLOOM, BR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (04) :1111-1122
[9]   DISSEMINATED TUBERCULOSIS IN INTERFERON-GAMMA GENE-DISRUPTED MICE [J].
COOPER, AM ;
DALTON, DK ;
STEWART, TA ;
GRIFFIN, JP ;
RUSSELL, DG ;
ORME, IM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2243-2247
[10]  
DELIBERO G, 1988, EUR J IMMUNOL, V18, P59, DOI 10.1002/eji.1830180110